Just Earth News | @justearthnews | 21 Jun 2020, 09:36 pm Print
Pixabay
Abuja: A team of Nigerian scientists are claiming they have created a vaccine which may help prevent the novel coronavirus infection, media reports said.
Universities’ Scientists, under the aegis of COVID-19 Research Group, on Friday made the announcement on the vaccine.
Addressing a news conference on Friday at Adeleke University, Ede, in Osun, Dr Oladipo Kolawole, Leader of the team, said the vaccine was being developed locally in Africa for Africans, reports The Guardian Nigeria.
Kolawole, a Specialist in Medical Virology, Immunology and Bioinformatics, at Adeleke University, Ede, however, said the vaccine would also work for other continents when unveiled.
Kolawole was quoted as saying by the newspaper that after trying out some selected processes of vaccine development, the researchers had been able to choose the best potential vaccine candidates for the SARS-CoV-2 and had made the possible latent vaccine constructs.
He said it will take 18 months for the vaccine to be available to the public.
Prof. Julius Oloke, the Head, Coordinating Unit of the Research Group and Vice-Chancellor of Precious Cornerstone University, Ibadan, said the vaccine was real.
He said, “It’s a pleasure that we have come together to produce a vaccine at a time that the world is in need of solution to a ravaging pandemic."
“It’s a proof that we are working and not folding our hands or looking away from the problem.
“The vaccine is real. We have validated it severally. It is targeted at Africans, but will also work for other races.
“It will work. It cannot be faked. This is a result of the determination. It took a lot of scientific efforts," he said.
- Which is the best time for workout to protect your heart? New study gives the answer
- Warning: Heavy smartphone use tied to body dissatisfaction and disordered eating
- Silent killer rising: Young women face surge in heart disease deaths
- Morning fitness secret: Why early risers are healthier, says study
- New study finds low to moderate wine consumption shows lower risk compared with spirits, beer and cider

